Innovation Blogs
09|17|25
Decoding the Future of Healthcare: What Patients Want from Their Digital Health Experience
What do patients really want from their digital health experiences? At Fierce Pharma Week 2025, industry leaders tackled this question head-on. Dan Gandor, EVP, Head of Omnichannel & Digital Transformation, delivered a compelling vision for the future, one that places patient needs and expectations at the heart of innovation.
08|26|25
EVERSANA Merges with Waltz Health to Create a New Force in Pharma Commercialization and Prescription Drug Access
EVERSANA and Waltz Health today announced a merger to form a unified healthcare platform that redefines pharmaceutical commercialization and patient access. The move integrates Waltz Health’s software-powered drug-price marketplaces and direct-to-payer model into EVERSANA’s global commercialization services, creating a next-generation approach for drug access and value in the U.S. healthcare system.
08|04|25
EVERSANA Announces Development of End-to-End AI-Powered Life Sciences Marketing Agency Built on Google Cloud Technology
CHICAGO – August 4, 2025 – EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today launched a groundbreaking pharmaceutical marketing AI agency running on an end-to-end AI-powered delivery platform built on Google Cloud technology. The AI Agency, actively deployed and validated for multiple pharmaceutical brands, is 80% AI-powered and automated, reducing marketing costs and […]
06|16|25
MM+M Top 100 2025: Evolved for Where Pharma’s Going
Discover how EVERSANA INTOUCH secured a top 10 spot in the MM+M Agency 100 list and learn how we've evolved for where pharma's going with a unique approach to pharma marketing.
06|13|25
AI in Oncology: Solving the Sequencing Puzzle in a Biomarker-Driven Era
At ASCO 2025, artificial intelligence took center stage as a real-world solution to one of oncology’s most complex challenges: sequencing treatments in a rapidly expanding biomarker landscape. In a recent PharmaLive article, Tim Lewis, EVP of Strategic Development, Oncology and Precision Medicine at EVERSANA INTOUCH, shared how AI is helping oncologists make faster, smarter decisions when evidence is […]
06|10|25
AI, Biomarkers & The Future of Oncology: Expert Insights From ASCO 2025
At this year’s ASCO Annual Meeting, the future of oncology came into sharper focus — and EVERSANA INTOUCH was at the center of the conversation. From the expanding role of AI to the evolving biomarker landscape, our experts shared insights that are shaping the future of cancer care.
05|21|25
Big Moves for Bigger Impact: Elevating Agency Leadership to Enhance Client Success
EVERSANA INTOUCH announced new leadership appointments in a recent press release. Read the blog for details about the leadership changes and how they will enhance client success.
05|21|25
EVERSANA Elevates Agency Leadership Team with Key Talent to Drive Innovation and Maximize Impact for Pharma Brands
CHICAGO– May 21, 2025 – EVERSANA, a leading provider of commercial services to the life sciences industry, today announced new appointments to the company’s global agency network, EVERSANA INTOUCH, to meet growing client needs.
04|11|25
EVERSANA Unveils EVERSANA ORCHESTRATE™ MLR to Transform the Medical, Legal & Regulatory Process
CHICAGO – 10 April, 2025 – EVERSANA, a leading provider of commercial services to the life sciences industry, today announced the next milestone in its journey to transform and innovate commercialization with the launch of EVERSANA ORCHESTRATE MLR, an AI-powered, industry-integrated platform that revolutionizes the Medical, Legal, and Regulatory (MLR) process.
02|28|25
Make a Difference in Rare Disease With Creativity, Data, and Innovation: Insights from Ann Cave
Learn the key takeaways and insights from a recent Med Ad News article about how to make a difference in rare disease marketing with creativity, data and innovation.